Kingsview Wealth Management, LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1791965
GRANTS PASS, OR
Position in VKTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$715,066
+$129,073 QoQ
Shares Held
21,975
+31.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kingsview Wealth Management, LLC holds $3,730,947 across 13 Biotechnology names. VKTX ranks #1 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
This page
|
21,975 | $715,066 | |
| 2 | IMRX |
Immuneering Corp
|
122,200 | $643,994 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
739 | $570,980 | |
| 4 | INSM |
INSMED Inc
|
2,089 | $341,593 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
1,806 | $305,250 | |
| 6 | INCY |
Incyte Corp
|
3,134 | $294,972 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
545 | $243,364 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
15,770 | $188,136 |
All Filings in VKTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $715,066 | 21,975 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $585,993 | 16,657 | Shares | Sole | 2026-02-09 | |
| 2024-09-30 | $218,102 | 3,445 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||